Effects of COVID-19 and Its Vaccination on Bullous Pemphigoid

The COVID-19 pandemic has highlighted the connection between systemic health and dermatology, with skin manifestations such as rashes and telogen effluvium serving as indicators of the disease. While COVID-19 vaccines have been effective in preventing severe illness, they have also been associated with dermatological side effects, including reactions linked to autoimmune diseases like Bullous Pemphigoid. Most vaccine-induced skin reactions are minor and self-resolving, but recognizing them is important to alleviate patient concerns and combat vaccine hesitancy. Dermatologists play a key role in diagnosing and managing these conditions, emphasizing the need for multidisciplinary public health approaches. Ongoing research into skin biomarkers and vaccine effects will further integrate dermatology into systemic disease management, improving patient outcomes as the pandemic becomes endemic.